MedTrace Logo

Paravertebral Block for Percutaneous Nephrolithotomy

NCT01480102 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2019-03-14

No results posted yet for this study

Summary

This study will compare post-operative pain levels in patients who receive paravertebral block prior to Percutaneous Nephrolithotomy (PCNL) surgery versus those who do not receive the block. We hypothesize that patients who receive the block will have lower post-operative pain scores and require less narcotics.

Conditions

  • Post Operative Pain

Interventions

DRUG

Group A-Paravertebral block

Bupivicaine 0.5% without epinephrine (100mg)20cc will be injected into the T10 paravertebral space. Active Group

OTHER

Group B- No block

direct pressure for 5 minutes will be held at the site of the where the local anesthetic was applied to mimic the application of the block.

Sponsors & Collaborators

  • Loyola University

    lead OTHER

Principal Investigators

  • Thomas Turk · Loyola Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2020-08-31
Completion
2021-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01480102 on ClinicalTrials.gov